Martha Morrell - Feb 21, 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Leah Akin, Attorney-in-Fact
Stock symbol
NPCE
Transactions as of
Feb 21, 2025
Transactions value $
-$1,074,844
Form type
4
Date filed
2/25/2025, 06:52 PM
Previous filing
Jan 31, 2025
Next filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Sale -$1.07M -78.3K -48.86% $13.72 82K Feb 21, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.21, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.